A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 308,924 shares of MRK stock, worth $30.1 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
308,924
Previous 137,645 124.44%
Holding current value
$30.1 Million
Previous $17 Million 105.87%
% of portfolio
0.37%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $19 Million - $22.1 Million
171,279 Added 124.44%
308,924 $35.1 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $4.86 Million - $5.22 Million
-39,263 Reduced 22.19%
137,645 $17 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $3.7 Million - $4.31 Million
32,700 Added 22.68%
176,908 $23.3 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $5.39 Million - $5.87 Million
53,836 Added 59.57%
144,208 $15.7 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $365,575 - $405,985
3,551 Added 4.09%
90,372 $9.3 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $9.19 Million - $10 Million
-84,621 Reduced 49.36%
86,821 $10 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $380,363 - $424,407
-3,695 Reduced 2.11%
171,442 $18.2 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $368,034 - $471,870
-4,209 Reduced 2.35%
175,137 $19.4 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $498,304 - $559,789
-5,895 Reduced 3.18%
179,346 $15.4 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $587,101 - $665,508
7,032 Added 3.95%
185,241 $16.9 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $5.03 Million - $5.63 Million
-68,360 Reduced 27.72%
178,209 $14.6 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $6.27 Million - $7.86 Million
86,773 Added 54.3%
246,569 $18.9 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $1.37 Million - $1.5 Million
19,085 Added 13.56%
159,796 $12 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $2.03 Million - $2.24 Million
-28,843 Reduced 17.01%
140,711 $10.9 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $3.92 Million - $4.62 Million
56,969 Added 50.6%
169,554 $13.1 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $3.83 Million - $4.25 Million
-53,321 Reduced 32.14%
112,585 $9.21 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $7.63 Million - $8.65 Million
-104,260 Reduced 38.59%
165,906 $13.8 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $2.05 Million - $2.34 Million
-29,155 Reduced 9.74%
270,166 $20.9 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $4.08 Million - $5.65 Million
-64,358 Reduced 17.7%
299,321 $23 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $19.5 Million - $22.1 Million
-251,954 Reduced 40.93%
363,679 $33.1 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $1.05 Million - $1.14 Million
13,788 Added 2.29%
615,633 $51.8 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $7.41 Million - $8.65 Million
106,071 Added 21.4%
601,845 $50.5 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $3.15 Million - $3.59 Million
45,283 Added 10.05%
495,774 $41.2 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $5.99 Million - $6.95 Million
91,861 Added 25.61%
450,491 $34.4 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $1.82 Million - $2.14 Million
-31,484 Reduced 8.07%
358,630 $25.4 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $17.9 Million - $21 Million
-352,359 Reduced 47.46%
390,114 $23.7 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $1.33 Million - $1.55 Million
26,165 Added 3.65%
742,473 $40.4 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $29 Million - $34.6 Million
561,991 Added 364.18%
716,308 $40.3 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $9.05 Million - $9.74 Million
154,317
154,317 $9.88 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.